Continuous ambulatory peritoneal dialysis with a high flux membrane. 1993

K D Nolph, and H L Moore, and B Prowant, and Z J Twardowski, and R Khanna, and S Gamboa, and P Keshaviah
Department of Internal Medicine, University of Missouri, Columbia 65212.

The standard peritoneal equilibration test (PET) was performed in 66 patients on CAPD. Patients were classified as low (n = 5), low average (n = 22), high average (n = 27), and high (n = 12) transporters based on the dialysate/plasma creatinine (D/P Cr) after 4 hour dwells. After an average time interval of 14 months on CAPD, indices of dialysis adequacy and nutrition were assessed. Based on monitoring of patient chemistries and drain volumes, peritoneal transport was considered stable during the interval. Instilled volumes and exchange tonicity were individualized in each patient to achieve combined renal and dialysis weekly creatinine clearance and KT/V urea that were not significantly different between groups. Overall, there were significant positive correlations of PET D/P Cr with dialysate albumin concentrations (r = 0.30, p < 0.02) and dialysate albumin losses (g/wk, r = 0.27, p < 0.04). There were significant inverse correlations with lean body mass (r = -0.26, p < 0.03), drain volumes (r = -0.025, p < 0.04), and KT urea by dialysis (L/wk, r = -0.24, p < 0.05). High transporters had significantly (p < 0.05) lower mean serum albumin, net protein catabolic rate (nPCR), lean body mass calculated from creatinine kinetics, and daily creatinine production (and presumably lower muscle mass) compared with one or more lower transport groups. In conclusion, we hypothesize that, in high transporters, use of more hypertonic exchanges with greater glucose absorption may inhibit appetite and nPCR; also, protein losses in drain volumes are increased. High transporters may require increased clearance and protein intake targets compared with other groups to maintain nutrition.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008567 Membranes, Artificial Artificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis (RENAL DIALYSIS), monomolecular and bimolecular membranes used as models to simulate biological CELL MEMBRANES. These membranes are also used in the process of GUIDED TISSUE REGENERATION. Artificial Membranes,Artificial Membrane,Membrane, Artificial
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D012709 Serum Albumin A major protein in the BLOOD. It is important in maintaining the colloidal osmotic pressure and transporting large organic molecules. Plasma Albumin,Albumin, Serum

Related Publications

K D Nolph, and H L Moore, and B Prowant, and Z J Twardowski, and R Khanna, and S Gamboa, and P Keshaviah
November 1984, The Journal of pediatrics,
K D Nolph, and H L Moore, and B Prowant, and Z J Twardowski, and R Khanna, and S Gamboa, and P Keshaviah
January 1986, Nephron,
K D Nolph, and H L Moore, and B Prowant, and Z J Twardowski, and R Khanna, and S Gamboa, and P Keshaviah
January 1981, Duodecim; laaketieteellinen aikakauskirja,
K D Nolph, and H L Moore, and B Prowant, and Z J Twardowski, and R Khanna, and S Gamboa, and P Keshaviah
October 1982, Gaceta medica de Mexico,
K D Nolph, and H L Moore, and B Prowant, and Z J Twardowski, and R Khanna, and S Gamboa, and P Keshaviah
November 1982, Deutsche medizinische Wochenschrift (1946),
K D Nolph, and H L Moore, and B Prowant, and Z J Twardowski, and R Khanna, and S Gamboa, and P Keshaviah
September 1980, Annals of internal medicine,
K D Nolph, and H L Moore, and B Prowant, and Z J Twardowski, and R Khanna, and S Gamboa, and P Keshaviah
November 1982, American journal of kidney diseases : the official journal of the National Kidney Foundation,
K D Nolph, and H L Moore, and B Prowant, and Z J Twardowski, and R Khanna, and S Gamboa, and P Keshaviah
November 1982, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
K D Nolph, and H L Moore, and B Prowant, and Z J Twardowski, and R Khanna, and S Gamboa, and P Keshaviah
September 1980, La Revue du praticien,
K D Nolph, and H L Moore, and B Prowant, and Z J Twardowski, and R Khanna, and S Gamboa, and P Keshaviah
January 1980, Medicina,
Copied contents to your clipboard!